A preclinical and clinical study of mycophenolate mofetil in pancreatic cancer Full Text
Investigational New Drugs, 06/13/2012
Rodriguez–Pascual J et al. – This study shows the feasibility of translating a preclinical observation to the clinical setting and to explore a drug mechanism of action in patients. MPA, however, did not show any hints of antiangiogenesis of anticancer clinical activity questioning if this agent should be further developed in PDA.